SCI Innovation Awards
SCI Innovation Awards
- Steven Corsello, MD
Degron-controlled base editors for massively scalable gene variant screens - Kyle Daniels, PhD
High-throughput engineering of receptors and signaling adapters to program anti-tumor macrophages - Lipika Goyal, MD; Edgar Engleman, MD; Daniel Delitto, MD, PhD; Gregory Charville, PhD
Elucidating mechanisms of lymph node metastatic tolerance in high-risk resectable cholangiocarcinoma - Sydney Lu, MD, PhD
Regulation of mRNA 3’ end formation by recurrent RNA splicing factor mutations - Dawn Siegel, MD; Albert Chiou, MD, MBA
Co-design of an educational intervention for melanoma prevention and awareness for teens - Alice Ting, PhD
A synthetic GPCR platform for cell-based cancer therapy
SCI Pancreatic Cancer Innovation Awards
- Katherine Ferrara, PhD
Claudin-4-targeted imaging and readiothergnostics to treat pancreatic cancer - Sarah Heilshorn, PhD; Calvin Kuo, MD, PhD; Christina Curtis, PhD
Engineering of personalized medicine organoids for pancreatic ductal adenocarcinoma
SCI Women’s Cancer Center Innovation Award
- Ami Bhatt, MD, PhD; Allison Kurian, MD, MSc
The microbiome as a modulator of immunotherapy treatment response in triple negative breast cancer - Paul Blumenthal, MD, MPH; Emily McClung, MD; Michelle Khan, MD, MPH
Innovating for treatment of cervical pre-cancer: Novel use and application of trichoroacetic acid (TCA) to treat cervical dysplasia with an ultimate focus on low-resource settings - Livnat Jerby, PhD
Reprogramming lymphocyte migration to overcome immune exclusion in breast cancer – towards cell therapies with spatial specificity - Derick Okwan, MD, PhD; Edgar Engleman, MD
Treatment of breast cancer through reversal of bacteria-induced neutrophil-mediated immunosuppression - Fauzia Riaz, MD; Candice Thompson, MD; Melinda Telli, MD
Circulating tumor-DNA detection in early stage triple negative and HER2-positive breast cancer - Lei Xing, PhD; James Zou, PhD; Max Diehn, MD, PhD
Biology-aware deep learning for prediction of outcome of cancer immunotherapy with immune checkpoint inhibitors - James Zou, PhD
Systematic pan-cancer analysis of sex dimorphism in response to treatments using large real-world clinicogenomics data
Shmunis Family Innovation Awards in Cancer Therapeutics
- Carolyn Bertozzi, PhD
From inhibition to activation: A novel siglec-based strategy for cancer immunotherapy - Kacper Rogala, PhD
Targeting Hyperactive mTORC2 in Lung Cancer
Behar Innovation Award in Sarcoma Research
- Anusha Kalbasi, MD
Immunotherapeutic targeting of fusion oncogenes in sarcoma
SUBMISSION DEADLINE: October 24, 2023
RFA Announced: September 5, 2023
Notification of Selection: December 15, 2023
Funding Period: March 1, 2024 – February 28, 2025